In this paper, we extend the vertical modeling approach for the analysis of survival data with competing risks to incorporate a cure fraction in the population, that is, a proportion of the population for which none of the competing events can occur. The proposed method has three components: the proportion of cure, the risk of failure, irrespective of the cause, and the relative risk of a certain cause of failure, given a failure occurred. Covariates may affect each of these components. An appealing aspect of the method is that it is a natural extension to competing risks of the semiparametricmixture curemodel in ordinary survival analysis; thus, causes of failure are assigned only if a failure occurs. This contrasts with the existing mixtu...
The thesis concerns regression models related to the competing risks setting in survival analysis an...
Competing risk or "multiple cause" survival data arise in medical, criminological, financial, engine...
Due to significant progress in cancer treatments and management in survival studies involving time t...
We propose vertical modelling as a natural approach to the problem of analysis of competing risks da...
In competing risks cure models, if there is unobserved heterogeneity among susceptible patients, app...
In survival analysis it often happens that a certain fraction of the subjects under study never expe...
In survival analysis, it often happens that a certain fraction of the subjects under study never exp...
Probability models for survival times of patients treated for a disease are often interpreted as tho...
The mixture cure model is a developed statistical survival model. It assumes that the studied popula...
International audienceCure models have been developed to analyze failure time data with a cured frac...
In survival analysis it often happens that some subjects under study do not experience the event of ...
We propose a method to analyse competing risks survival data when failure types are missing for some...
Cure models are a special type of survival analysis model where it is assumed that there are a propo...
Competing risks occur often in survival analysis. In present work, we study different ap- proaches t...
In survival analysis, the survival time is assumed to follow a non-negative distribution, such as th...
The thesis concerns regression models related to the competing risks setting in survival analysis an...
Competing risk or "multiple cause" survival data arise in medical, criminological, financial, engine...
Due to significant progress in cancer treatments and management in survival studies involving time t...
We propose vertical modelling as a natural approach to the problem of analysis of competing risks da...
In competing risks cure models, if there is unobserved heterogeneity among susceptible patients, app...
In survival analysis it often happens that a certain fraction of the subjects under study never expe...
In survival analysis, it often happens that a certain fraction of the subjects under study never exp...
Probability models for survival times of patients treated for a disease are often interpreted as tho...
The mixture cure model is a developed statistical survival model. It assumes that the studied popula...
International audienceCure models have been developed to analyze failure time data with a cured frac...
In survival analysis it often happens that some subjects under study do not experience the event of ...
We propose a method to analyse competing risks survival data when failure types are missing for some...
Cure models are a special type of survival analysis model where it is assumed that there are a propo...
Competing risks occur often in survival analysis. In present work, we study different ap- proaches t...
In survival analysis, the survival time is assumed to follow a non-negative distribution, such as th...
The thesis concerns regression models related to the competing risks setting in survival analysis an...
Competing risk or "multiple cause" survival data arise in medical, criminological, financial, engine...
Due to significant progress in cancer treatments and management in survival studies involving time t...